First-stage testing on the drug, which is from Merck and Ridgeback Biotherapeutics, showed "promising signs of effectiveness in reducing the virus in patients," the outlet noted.
The drug, according to Fox, would be used at home as a five-day treatment, not unlike how Tamiflu is prescribed to combat the effects of influenza.
No comments:
Post a Comment